BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15763201)

  • 21. [Interest in ophthalmologic examination for familial adenomatous polyposis].
    Collignon N; Collignon-Brach J; Galand A
    Bull Soc Belge Ophtalmol; 1999; 274():11-6. PubMed ID: 10670158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome).
    Traboulsi EI; Murphy SF; de la Cruz ZC; Maumenee IH; Green WR
    Am J Ophthalmol; 1990 Nov; 110(5):550-61. PubMed ID: 2173407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of congenital hypertrophy of the retinal pigment epithelium as diagnostic marker in familial adenomatous polyposis].
    Chagas C; Fidalgo P; Martins A; Barata A; Leitão CN; Mira FC; Ramalho PS
    Acta Med Port; 1993 Jul; 6(7):303-6. PubMed ID: 8397471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gardner syndrome. Significance of ocular features.
    Lewis RA; Crowder WE; Eierman LA; Nussbaum RL; Ferrell RE
    Ophthalmology; 1984 Aug; 91(8):916-25. PubMed ID: 6493700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP).
    Rossato M; Rigotti M; Grazia M; Turco AE; Bonomi L
    Acta Ophthalmol Scand; 1996 Aug; 74(4):338-42. PubMed ID: 8883546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.
    Nieuwenhuis MH; Vasen HF
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):153-61. PubMed ID: 17064931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.
    Martow J; Polomeno RC; Lewandowski R; Daly D; Miller S; Jutras L; Koehn D; Der Kaloustian VM
    Can J Ophthalmol; 1990 Oct; 25(6):290-2. PubMed ID: 2174290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis.
    Iwama T; Mishima Y; Okamoto N; Inoue J
    Br J Surg; 1990 Mar; 77(3):273-6. PubMed ID: 2157519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congenital hypertrophy of retinal pigment epithelium: a marker in familial adenomatous polyposis].
    Szwarcberg J; Limacher JM; Fricker JP; Flament J
    J Fr Ophtalmol; 1999 Apr; 22(3):364-70. PubMed ID: 10337595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.
    Lam DS; Kwok SP; Kwok AK; Liew CT; Lau JW; Pang CC
    Chin Med J (Engl); 1998 Mar; 111(3):278-81. PubMed ID: 10374435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple gynecologic tumors as rare associated phenotypes of FAP/Gardner syndrome in a family with the novel germline mutation in the APC gene.
    Kovac M; Tomka M; Ciernikova S; Stevurkova V; Valachova A; Zajac V
    Clin Genet; 2006 Feb; 69(2):183-6. PubMed ID: 16433700
    [No Abstract]   [Full Text] [Related]  

  • 32. [Congenital hypertrophy of the pigment epithelium].
    Cohen SY; Quentel G; Guiberteau B; Sterkers M; Coscas G
    J Fr Ophtalmol; 1992; 15(3):213-9. PubMed ID: 1640080
    [No Abstract]   [Full Text] [Related]  

  • 33. Gardner syndrome: skin manifestations, differential diagnosis and management.
    Juhn E; Khachemoune A
    Am J Clin Dermatol; 2010; 11(2):117-22. PubMed ID: 20141232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescein angiographic features of the congenital hypertrophy of the retinal pigment epithelium in the familial adenomatous polyposis.
    Touriño R; Rodríguez-Ares MT; López-Valladares MJ; Gómez-Ulla F; Gómez-Torreiro M; Capeans C
    Int Ophthalmol; 2005; 26(1-2):59-65. PubMed ID: 16779566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torpedo-like lesions in the ocular fundi of Gardner syndrome: hiding in plain view.
    Packo K; Goldberg MF
    Ophthalmic Genet; 2021 Oct; 42(5):514-520. PubMed ID: 34014136
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic value of ocular manifestations in Gardner syndrome].
    Díaz Llopis M; Marín F; Harto M; Sala T; Martínez-Costa R; Menezo JL
    Rev Esp Enferm Apar Dig; 1987 Nov; 72(5 Pt 2):613-6. PubMed ID: 3448696
    [No Abstract]   [Full Text] [Related]  

  • 37. Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder.
    Gómez García EB; Knoers NV
    Lancet Oncol; 2009 Jul; 10(7):727-35. PubMed ID: 19573802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactinoma as the first manifestation of Gardner's syndrome.
    Goodin GS; McCarville MB; Thibodeau SN; Skapek SX; Khoury JD; Spunt SL
    Pediatr Blood Cancer; 2008 Feb; 50(2):409-12. PubMed ID: 16862550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital hypertrophy of the retinal pigment epithelium predicts colorectal polyposis in Gardner's syndrome.
    Traboulsi EI; Maumenee IH; Krush AJ; Alcorn D; Giardiello FM; Burt RW; Hughes JP; Hamilton SR
    Arch Ophthalmol; 1990 Apr; 108(4):525-6. PubMed ID: 2157384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis.
    Wallis YL; Macdonald F; Hultén M; Morton JE; McKeown CM; Neoptolemos JP; Keighley M; Morton DG
    Hum Genet; 1994 Nov; 94(5):543-8. PubMed ID: 7959691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.